Posaconazole Impurity 74
|
泊沙康唑雜質(zhì)74
|
|
Dextrorphan L-Tartrate (Dextromethorphan EP Impurity B L-Tartrate)
|
右美沙芬L -酒石酸酯(右美沙芬EP雜質(zhì)B L -酒石酸酯)
|
143-98-6
|
Ticagrelor Impurity 8
|
替格瑞洛雜質(zhì)8
|
|
Baricitinib Impurity 26
|
巴瑞替尼雜質(zhì)26
|
25240-33-9
|
Atomoxetine Impurity 11
|
托莫西汀雜質(zhì)11
|
|
Posaconazole Diastereoisomer 4 (S,S,R,S)
|
泊沙康唑非對(duì)映異構(gòu)體4(S,S,R,S)
|
|
Dehydro Risperidone
|
脫氫利培酮
|
168906-58-9
|
Risperidone Impurity 10
|
利培酮雜質(zhì)10
|
59084-16-1
|
Glycopyrronium Bromide EP Impurity J
(Glycopyrrolate USP Related Compound C)
|
格隆溴銨EP雜質(zhì)J
|
427-49-6
|
1,4-dimethyl-2-nitrobenzene
|
1,4-二甲基-2-硝基苯
|
89-58-7
|
Ticagrelor Impurity 107
|
替格瑞洛雜質(zhì)107
|
|
Linagliptin Impurity 35
|
利格列汀雜質(zhì)35
|
2138392-83-1
|
Atomoxetine Impurity 15
|
托莫西汀雜質(zhì)15
|
881995-45-5
|
Posaconazole Impurity 113
|
泊沙康唑雜質(zhì)113
|
|
Linagliptin Impurity 20
|
利格列汀雜質(zhì)20
|
2514949-81-4
|
Atomoxetine EP Impurity H HCl
|
托莫西汀EP雜質(zhì)H鹽酸鹽
|
|
Posaconazole Impurity 135
|
泊沙康唑雜質(zhì)135
|
|
Linagliptin Impurity 116
|
利格列汀雜質(zhì)116
|
|
Glycopyrrolate Erythro Isomer (RR-Isomer)
|
格隆溴銨赤式異構(gòu)體(RR-異構(gòu)體)
|
475468-09-8
|
Baricitinib Impurity 6
|
巴瑞替尼雜質(zhì)6
|
2964606-42-4
|
Glycopyrronium Bromide EP Impurity G HCl
|
格隆溴銨EP雜質(zhì)G鹽酸鹽
|
13118-10-0
|
Chlorhexidine Digluconate Solution EP Impurity J D-Gluconate
|
二葡糖酸氯己定溶液EP雜質(zhì)J D-葡糖酸
|
|
Baricitinib Impurity 20
|
巴瑞替尼雜質(zhì)20
|
24566-95-8
|
Tedizolid Impurity 61
|
特地唑胺雜質(zhì)61
|
60456-26-0
|
Dapoxetine Impurity ZY9
|
達(dá)泊西汀雜質(zhì)ZY9
|
|
Avibactam Impurity ZY2
|
阿維巴坦雜質(zhì)ZY2
|
|
Posaconazole Diastereoisomer 8 (R,S,S,S)
|
泊沙康唑非對(duì)映異構(gòu)體8(R,S,S,S)
|
|
BenzylposaconazoleEnantiomer
|
芐基泊沙康唑?qū)τ丑w
|
|
Dextromethorphan Impurity ZY1
|
右美沙芬雜質(zhì)ZY1
|
|
Glycopyrronium Bromide EP Impurity I Bromide (SR-Isomer) (Glycopyrrolate USP Related Compound I (SR-Isomer))
|
格隆溴銨EP雜質(zhì)I溴化物(SR-異構(gòu)體)
|
|
Linagliptin Impurity 95
|
利格列汀雜質(zhì)95
|
|
Linagliptin impurity 111
|
利格列汀雜質(zhì)111
|
|
Risperidone Impurity 22 HCl
|
利培酮雜質(zhì)22HCl
|
|
4’-Hydroxy Atomoxetine Glucuronide
|
4'-羥基托莫西汀葡萄糖醛
|
540729-08-6
|
Azithromycin EP Impurity F
|
阿奇霉素EP雜質(zhì)F
|
612069-28-0
|
Ticagrelor Impurity 81
|
替格瑞洛雜質(zhì)81
|
1006376-62-0
|
rac-Dapoxetine HCl
|
rac-鹽酸達(dá)泊西汀
|
1071929-03-7
|
Dapoxetine 2-Naphthyl Impurity
|
達(dá)泊西汀2-萘基雜質(zhì)
|
|
Tedizolid Impurity 10
|
特地唑胺雜質(zhì)10
|
1056039-83-8
|
Bicyclo Risperidone Iodide
|
雙環(huán)利培酮碘
|
2231638-02-9
|
Posaconazole Enantiomer
|
泊沙康唑?qū)τ丑w
|
2243785-97-7
|
Linagliptin Dimer Impurity 2
|
利格列汀二聚體雜質(zhì)2
|
1418133-47-7
|
Posaconazole Impurity 8
|
泊沙康唑雜質(zhì)8
|
|
Avibactam Impurity 6
|
阿維巴坦雜質(zhì)6
|
1192651-49-2
|
Ticagrelor Related Compound 21
|
替格瑞洛相關(guān)雜質(zhì)21
|
|
Ticagrelor Impurity 110 HCl
|
替格瑞洛雜質(zhì) 110 鹽酸鹽
|
1990505-73-1
|
Lidocaine Impurity 1
|
利多卡因雜質(zhì)1
|
|
Posaconazole Diastereoisomer 7 (R,S,R,S)
|
泊沙康唑非對(duì)映異構(gòu)體7(R,S,R,S)
|
213381-04-5
|
Linagliptin Impurity 4
|
利格列汀雜質(zhì)4
|
|
|
阿維巴坦對(duì)映異構(gòu)體鈉鹽
|
1383814-68-3
|
Tedizolid Impurity 30
|
特地唑胺雜質(zhì)30
|
1771765-84-4
|
Linagliptin Impurity 90 HCl
|
利格列汀雜質(zhì)90鹽酸
|
1791405-13-4
|
Tedizolid Impurity 74
|
特地唑胺雜質(zhì)74
|
|
Posaconazole Impurity 37
|
泊沙康唑雜質(zhì)37
|
|
Posaconazole Impurity 61
|
泊沙康唑雜質(zhì)61
|
|
Ticagrelor Impurity 26
|
替格瑞洛雜質(zhì)26
|
|
Tedizolid Impurity 65
|
特地唑胺雜質(zhì)65
|
97483-77-7
|
Glycopyrronium Bromide EP Impurity M
|
格隆溴銨EP雜質(zhì)M
|
5422-88-8
|
Linagliptin Impurity 51
|
利格列汀雜質(zhì)51
|
2074688-82-5
|
Ticagrelor Impurity 35
|
替格瑞洛雜質(zhì) 35
|
|
Ticagrelor Impurity 60
|
替格瑞洛雜質(zhì) 60
|
|
Ticagrelor Impurity 67
|
替格瑞洛雜質(zhì)67
|
|
Ticagrelor Impurity 68
|
替格瑞洛雜質(zhì)F (替格瑞洛雜質(zhì)68)
|
1643378-46-4
|
Dapoxetine Impurity 22
|
達(dá)泊西汀雜質(zhì)22
|
|
Linagliptin Impurity 56
|
利格列汀雜質(zhì)56
|
|
Linagliptin Impurity 61
|
利格列汀雜質(zhì)61
|
|
Piperacillin Impurity 13
|
哌拉西林雜質(zhì)13
|
|
Ticagrelor Impurity 16
|
替格瑞洛雜質(zhì)16
|
|
Ticagrelor Impurity 22
|
替格瑞洛雜質(zhì)22
|
|
Ticagrelor Impurity 65
|
替格瑞洛雜質(zhì)65
|
1402150-10-0
|
Glycopyrrolate Impurity 18
|
格隆溴銨雜質(zhì)18
|
1404453-65-1
|
(1R,2S)-2-(2,5-difluorophenyl)cyclopropanamine
|
(1R,2S)-2-(2,5-二氟苯基)環(huán)丙胺
|
1415905-52-0
|
Baricitinib Impurity 16
|
巴瑞替尼雜質(zhì)16
|
2402776-84-3
|
Posaconazole Impurity 129
|
泊沙康唑雜質(zhì)129
|
|
Posaconazole Impurity 125
|
泊沙康唑雜質(zhì)125
|
|
Chlorhexidine Diacetate Impurity C
|
氯己定EP雜質(zhì)C
|
62247-48-7
|
Dapoxetine Impurity 8 HCl
|
達(dá)泊西汀雜質(zhì)8鹽酸鹽
|
|
Glycopyrrolate Impurity 10
|
格隆溴銨雜質(zhì)10
|
207856-85-7
|
Ticagrelor Related Compound 82
|
替格瑞洛相關(guān)化合物82
|
|
Glycopyrrolate Impurity 7
|
格隆溴銨雜質(zhì)7
|
64471-47-2
|
Posaconazole Impurity 58
|
泊沙康唑雜質(zhì)58
|
183871-34-3
|
(1R,2R)-2-(2,5-difluorophenyl)cyclopropanamine
|
(1R,2R)-2-(2,5-二氟苯基)環(huán)丙胺
|
|
(1S,2R)-2-(2,4-difluorophenyl)cyclopropanamine
|
(1S,2R)-2-(2,4-二氟苯基)環(huán)丙胺
|
|
Ticagrelor mixture 2
|
替格瑞洛混合物2
|
|
N-Nitroso Lidocaine
|
N-硝基利多卡因
|
|
Posaconazole Impurity 120
|
泊沙康唑雜質(zhì)120
|
|
Posaconazole Impurity 95
|
泊沙康唑雜質(zhì)95
|
|
Ticagrelor Impurity 91
|
替格瑞洛雜質(zhì)91
|
1820580-27-5
|
Baricitinib Impurity 19
|
巴瑞替尼雜質(zhì)19
|
|
Baricitinib Impurity 20 HCl
|
巴瑞替尼雜質(zhì)20鹽酸鹽
|
2641097-39-2
|
Azithromycin Impurity 3
|
阿奇霉素雜質(zhì)3
|
2365312-75-8
|
Ticagrelor Impurity 90
|
替格瑞洛雜質(zhì)90
|
376608-70-7
|
Posaconazole Impurity 106
|
泊沙康唑雜質(zhì)106
|
2069239-68-3
|
Linagliptin Impurity 101
|
利格列汀雜質(zhì)101
|
1573118-33-8
|
Ticagrelor Related Compound 97 (AR-C124910XX-O-Glucuronide)
|
替格瑞洛相關(guān)化合物 97 (AR-C124910XX-O-葡萄糖苷酸)
|
|
trans-Bilastine N-Oxide
|
反式比拉斯汀氮氧化物
|
1934257-94-9
|
Linagliptin Impurity 105
|
利格列汀雜質(zhì)105
|
|
Glycopyrrolate Impurity 27
|
格隆溴銨雜質(zhì)27
|
1332599-61-7
|
Posaconazole Diastereoisomer 12 (S,R,S,R)
|
泊沙康唑非對(duì)映異構(gòu)體12(S,R,S、R)
|
|
Tedizolid Impurity 63
|
特地唑胺雜質(zhì)63
|
2044710-49-6
|